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Abstract
Cancer cells exist in a mechanically and chemically heterogeneous microenvironment which undergoes dynamic changes
throughout neoplastic progression. During metastasis, cells from a primary tumor acquire characteristics that enable them
to escape from the primary tumor and migrate through the heterogeneous stromal environment to establish secondary
tumors. Despite being linked to poor prognosis, there are no direct clinical tests available to diagnose the likelihood of
metastasis. Moreover, the physical mechanisms employed by metastatic cancer cells to migrate are poorly understood.
Because metastasis of most solid tumors requires cells to exert force to reorganize and navigate through dense stroma, we
investigated differences in cellular force generation between metastatic and non-metastatic cells. Using traction force
microscopy, we found that in human metastatic breast, prostate and lung cancer cell lines, traction stresses were
significantly increased compared to non-metastatic counterparts. This trend was recapitulated in the isogenic MCF10AT
series of breast cancer cells. Our data also indicate that increased matrix stiffness and collagen density promote increased
traction forces, and that metastatic cells generate higher forces than non-metastatic cells across all matrix properties
studied. Additionally, we found that cell spreading for these cell lines has a direct relationship with collagen density, but a
biphasic relationship with substrate stiffness, indicating that cell area alone does not dictate the magnitude of traction
stress generation. Together, these data suggest that cellular contractile force may play an important role in metastasis, and
that the physical properties of the stromal environment may regulate cellular force generation. These findings are critical for
understanding the physical mechanisms of metastasis and the role of the extracellular microenvironment in metastatic
progression.
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Introduction
While significant advances have been made in the treatment of
primary tumors through surgery, chemotherapy and radiation
treatment, a mechanism for effectively diagnosing the likelihood of
metastasis remains elusive [1]. Metastasis is the leading cause of
death among cancer patients, resulting in over 90% of cancer-
related fatalities [2]. Moreover, there is currently no procedure or
test that can definitively determine the metastatic potential of a
specific tumor. Clinical oncologists routinely rely on pathology
reports and historical statistics to determine patient prognosis and
to design a course of palliative therapy [3].
Because metastasis has become the primary obstacle in cancer
treatment, there is a substantial body of work attempting to
discover a biological marker (or set of markers) for metastasis, but
with marginal success [4]. Previous studies have linked overex-
pression of VEGF-D [5], urokinase plasminogen activator [6], the
growth factor receptor CXCR2 [7] and activator protein-1 [8] to
increased metastatic breast cancer invasion in vitro and in vivo.
Additionally, studies have shown that a combination of genes can
affect organ-specific tropism [9]. However, these discoveries have
generally not been applicable to multiple cancer types, or even
within subtypes of a single cancer. Recently, advances in genetic
profiling have led to the identification of a 17-gene expression
signature for metastasis in primary adenocarcinomas [10], as well
as a 70-gene expression signature for predicting the clinical
prognosis of breast cancer [11]. While patients whose tumors
contain these expression patterns will benefit from this kind of
genetic analysis, it may not be applicable to a broad spectrum of
patients with heterogeneous tumor populations. Additionally,
while these signatures may show significant statistical correlation
with poor prognosis, they are not descriptive of the physical
behaviors of the tumor cells that lead to these clinical results.
Alterations in gene expression patterns result in phenotypic
changes at the cellular level during cancer progression. As such,
the biophysical characteristics of tumor cells may be a more
appropriate and accessible clinical indicator than individual
genetic alterations. During metastatic invasion, cancer cells
encounter a complex and constantly evolving microenvironment
[12] consisting of upregulated extracellular matrix proteins
[10,13,14], different degrees of extracellular matrix (ECM)
crosslinking [13], mechanical heterogeneity [15,16], varying
oxygen levels [17], as well as exposure to shear stress and
interstitial pressure [12]. To successfully navigate this dynamic
microenvironment, tumor cells must generate force to reorganize
the basement membrane, invade into surrounding stroma [18,19],
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endothelial cell barrier [7] to enter the circulatory or lympathic
system. In addition to enzymatically degrading the ECM with
matrix metalloproteinases, metastatic cells can use force to
mechanically rearrange their ECM to clear a path for migration
[18]. There is evidence from in vivo imaging that cells use re-
oriented fibers as ‘‘train-tracks’’ to guide their migration away
from the primary tumor [21]. Traction forces have previously
been shown to mediate normal cell migration [22], adhesion
[23,24], mechanotransduction [25], and ECM remodeling
[21,26,27]. Notably, these processes are also involved in cancer
progression. Paszek et al. have shown a marked difference in the
magnitude and organization of traction stresses between cancerous
and untransformed mammary epithelial cells, suggesting inherent
differences in cell force generation in the cancerous phenotype
[15]. However, the effects of metastatic potential on force
generation have not yet been thoroughly investigated.
Matrix stiffness has been shown to have a distinct effect on force-
mediated cellular behaviors including migration [28,29,30,31],
adhesion [25,32,33], and ECM remodeling [13,18]. Because
metastasizing cancer cells are exposed to both the increased stiffness
of the stroma surrounding most solid tumors, as well as more
compliant adipose tissue, it is important to understand the effects of
a dynamic mechanical environment on cancer cell force generation.
Similarly, ligand density has also been shown to have a significant
effect on the force generation of non-cancerous cell types, such as
endothelial cells and fibroblasts [34,35,36]. During cancer progres-
sion, the chemical nature of the extracellular matrix experiences
significant changes, affecting the number and nature of binding sites
available for tumor cell adhesion and migration. Collagen
metabolism has been shown to be dysregulated, with elevated
expression, increased deposition, and an increase in collagen
crosslinking that contributes to the overall stiffening of the
surrounding microenvironment [13]. These factors lead to an
increase in mammographic density, which has been specifically
correlated to an increased risk for the development of breast cancer
[37]. An increase in collagen expression has also been clinically
linked to metastatic tumors by genetic analysis of tumor biopsies
[10]. Therefore, understanding the independent and interdepen-
dent relationships between substrate mechanics, collagen density,
and force generation is critical for understanding the mechanism(s)
driving metastatic progression.
In this study, we investigate traction force generation as a
biophysical marker of metastatic potential. We quantify contractile
forces of highly metastatic breast, prostate, and lung cancer cell
lines compared to non-tumorigenic epithelial cell lines seeded on
substrates of varying stiffness and collagen density using traction
force microscopy. Here, we show that highly metastatic cancer
cells exert significantly increased forces across all matrix properties
studied. Moreover, our data show that increased matrix stiffness
and collagen density both promote increased traction forces.
These findings provide the first evidence to our knowledge that
differential force profiles of metastatic cells may aid in determining
metastatic potential.
Methods
Cell culture
MCF10A mammary epithelial cells (American Type Culture
Collection (ATCC), Rockville, MD) were maintained in Dulbec-
co’s Modified Eagle’s Media supplemented with 5% horse serum,
20 ng/mL EGF (Invitrogen, Carlsbad, CA), 10 mg/mL insulin,
0.5 mg/mL hydrocortisone, 100 ng/mL cholera toxin (Sigma-
Aldrich, St. Louis, MO), and 1% penicillin-streptomycin (Invitro-
gen) [38]. MDAMB231 highly metastatic breast adenocarcinoma
cells (ATCC) were maintained in Minimum Essential Medium
supplemented with 10% fetal bovine serum, and 1% penicillin-
streptomycin (Invitrogen). PC3 highly metastatic prostate adeno-
carcinoma cells (ATCC) were maintained in Kaighn’s Modifica-
tion of Ham’s F-12 Medium (ATCC) supplemented with 10% fetal
bovine serum and 1% penicillin-streptomycin (Invitrogen). PrEC
primary human prostate epithelial cells (Lonza, Walkersville, MD)
were maintained in PrEGM prostate epithelial cell growth
medium (Lonza) supplemented with SingleQuots (Lonza) accord-
ing to the manufacturer’s recommended protocol. BEAS2B
bronchial epithelial cells (ATCC) were maintained in BEBM
bronchial epithelial cell basal medium (Lonza) supplemented with
SingleQuots (Lonza) according to ATCC recommended protocol,
and 1% penicillin-streptomycin (Invitrogen). A549 metastatic lung
carcinoma cells (ATCC) were kindly provided by Paraskevi
Giannakakou (Weill Cornell Medical College) and were main-
tained in RPMI 1640 supplemented with 10% fetal bovine serum,
1% penicillin-streptomycin, and 1 mg/mL puromycin (Invitrogen).
MCF10AT1 transformed mammary epithelial cells and
MCF10CA1a metastatic mammary epithelial cells were obtained
from the Barbara Ann Karmanos Cancer Institute (Detroit, MI)
and were maintained in 1:1 Dulbecco’s Modified Eagle’s Media/
F12 supplemented with 5% horse serum, 20 ng/mL EGF
(Invitrogen), 10 mg/mL insulin, 0.5 mg/mL hydrocortisone,
100 ng/mL cholera toxin (Sigma-Aldrich), and 1% penicillin-
streptomycin (Invitrogen) [39]. All cells were cultured at 37uC and
5% CO2. Live cell imaging was performed in a custom
temperature, humidity, and CO2- controlled stage of a Zeiss Axio
Observer Z1m inverted phase contrast microscope with a
Hamamatsu ORCA-ER camera.
Substrate synthesis and traction force microscopy
Substrates of various Young’s moduli (1–10 kPa) were synthe-
sized with varying ratios of 3–7.5% acrylamide (40% w/v solution,
Bio-Rad, Hercules, CA) and 0.1–0.35% N,N9-methylene-bis-
acrylamide (2% w/v solution, Bio-Rad) as described previously
[24,40]. Substrate surfaces were functionalized using N-6-
((acryloyl)amido)hexanoic acid, synthesized in our lab [34],
covalently bound to 0.0001–0.1 mg/mL type I rat-tail collagen
(Becton Dickinson, Franklin Lakes, NJ). The Young’s modulus (E)
of the polyacrylamide substrates was verified as previously
described [32,34,40]. Traction force microscopy (TFM) was also
performed as previously described [40,41,42]. Briefly, cells were
seeded on polyacrylamide substrates (E=1–10 kPa) embedded
with 0.5-mm fluorescent beads and allowed to adhere overnight.
Cells were then imaged in phase and bead distributions were
imaged in fluorescence before and after removal of the cell with
trypsin. Bead displacement within the substrate was tracked with
correlation-based optical flow and converted into a strain field.
These strain fields were converted into traction stresses using the
LIBTRC analysis library developed by Professor Micah Dembo of
Boston University, who invented the basic theory that underlies
TFM [41]. Images were processed with LIBTRC software to
determine the cellular traction vectors, T, the total magnitude of
the force, |F|, and the projected cell area. |F| is an integral of the
traction field over the entire area of the cell,
DFD~
ð ð
T2
x x,y ðÞ zT2
y x,y ðÞ
   1=2
dxdy ð1Þ
where Tx ,y ðÞ ~ Tx x,y ðÞ ,Ty x,y ðÞ
  
is the continuous field of local
traction vectors defined at local spatial coordinates (x,y) in the
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condition.
Statistical tests
Data were compared with analysis of variance (ANOVA) and
with post-hoc Tukey’s Honestly Significantly Different (HSD) test
or Student’s t test where appropriate in JMP software (v.8, SAS,
Cary, NC). All data were logarithmically transformed prior to
analysis to ensure normal distribution. All data are reported as
mean 6 standard error of the mean (SEM).
Results
Metastatic cancer cells exert stronger traction forces
To investigate the relationship between cellular traction force
generation and metastatic potential, we examined the differences
in traction force generation in three independent cancer models:
breast, prostate, and lung cancer. These cancers comprise the
three most fatal cancers in both men and women [43], with
metastatic disease being the ultimate cause of death in over 90% of
these patients [2]. During metastatic progression, phenotypic
changes in cancer cells result in altered adhesion and migration
behavior, allowing cells to escape from the tumor mass into
surrounding tissue [12]. Because contractile force is known to
mediate these behaviors in normal cells [23,24], we hypothesized
that cancer cells require increased force generation to metastasize.
For each type of cancer, we chose a cell line (breast, prostate, lung,
respectively) that was previously characterized as highly invasive in
vitro and metastatic in vivo (MDAMB231, PC3, and A549), as well
as a non-tumorigenic, non-metastatic control cell population that
is representative of healthy native epithelial tissue (MCF10A,
PrEC, and BEAS-2B).
At a moderate stiffness mimicking tumorigenic conditions in
breast tissue (E=5 kPa) [15], measurements of cellular force using
TFM indicate that MDAMB231 highly metastatic breast cancer
cells exhibited stronger traction stresses compared to the non-
metastatic MCF10A mammary epithelial cells (Fig. 1A). Likewise,
both the PC-3 highly metastatic prostate cancer cells (Fig. 1B) and
the A549 metastatic lung cancer cells (Fig. 1C) exhibited
significantly greater traction stresses than the non-metastatic PrEC
primary prostate epithelial cells and the BEAS-2B lung epithelial
cells, respectively. These data suggest that increasing force
generation in cells of high metastatic potential may be a
biophysical characteristic of metastatic cells that could potentially
act as a mechanical marker for metastasis.
Substrate stiffness and collagen density mediate
magnitude of traction force
Because cancer cells encounter heterogeneous environments
exhibiting a range of stiffness during metastatic progression in vivo,
such as stiff, matrix-dense regions near the tumor and compliant
adipose tissue during stromal invasion [15], we measured the
traction forces exerted on substrates of varying stiffness (E=1–
10 kPa), with collagen density being held constant (0.1 mg/mL).
We found that, in addition to exerting greater forces on substrates
of tumorigenic stiffness (Fig. 1A), MDAMB231 cells also have a
greater overall net traction force (|F|) than MCF10A cells when
cultured on substrates of higher stiffness (E=10 kPa, Fig. 2A).
This trend was also recapitulated with the prostate and lung
cancer models, in which the metastatic PC3 (Fig. 2B) and A549
(Fig. 2C) prostate and lung cancer cells exerted significantly
greater forces than non-metastatic PrEC and BEAS2B cells on stiff
substrates. On more compliant substrates (E=1 kPa), the
metastatic cells of each cancer type studied exert slightly higher
forces than their non-metastatic counterparts. Additionally, we
observed a significant increase in net traction force with increasing
substrate stiffness within all 6 cell lines (p,0.01), suggesting that
the stiffness of the environment surrounding cancer cells can
directly contribute to the amount of traction force exerted at a
single cell level. These data indicate that the stiffness of the
microenvironment significantly affects the magnitude of forces
generated by metastatic and non-metastatic cells, and suggest that,
in general, metastatic cells are able to exert greater net traction
forces than non-metastatic cells.
Collagen content of the microenvironment also changes
throughout neoplastic progression [13], with increased collagen
expression particularly noted in clinical analyses of high grade
tumors [10]. As such, we examined the effect of collagen density
on cancer cell traction forces. Using substrates of constant stiffness
(E=5 kPa) and varying collagen density (0.0001–0.1 mg/mL), we
found that metastatic MDAMB231 breast cancer cells exert a
greater net traction force (|F|) than non-metastatic MCF10A cells
across the entire range of collagen densities tested (Fig. 3A). This
trend is recapitulated with both the prostate and the lung cells,
with metastatic PC3 (Fig. 3B) and A549 (Fig. 3C) prostate and
lung cancer cells exerting greater forces than their non-metastatic
counterparts, PrEC and BEAS2B cells, on substrates with varying
collagen density. Similar to the previously observed trend of
increasing force with increasing stiffness, all 6 cell lines also showed
a significant increase (p,0.01) in net traction force with increasing
collagen density, suggesting that increased collagen content within
the tumor microenvironment can also drive force generation of
cancer cells. Together these data indicate that metastatic and non-
metastatic cells have differential force profiles that are significantly
affected by mechanical and chemical matrix properties of the
tumor microenvironment.
Differences in force generation are not correlated to
differences in cell spreading
Because cellular force generation has been linked to cell spread
area in previous studies [34,36], we assessed whether increased
cellular traction force in metastatic cells on both stiff matrices and
those displaying high densities of collagen was simply caused by
an increase in cell area (i.e. that larger cells exert higher forces).
The area of isolated cells was measured during the TFM
experiments previously described. We observed no significant or
consistent trend when comparing the spreading area of metastatic
breast, prostate, and lung cancer cells to their non-metastatic
epithelial cell counterparts across substrates of constant collagen
density and varying stiffness (Fig. 4A) or across substrates of
constant stiffness and varying collagen density (Fig. 4B) (p.0.05).
These data indicate that the observed increases in traction force
in metastatic versus non-metastatic cells are not linked to cell
area. Interestingly, we noted that five of the six cell lines
(excluding the non-metastatic PrEC prostate epithelial cells)
exhibited a biphasic relationship with substrate stiffness, with the
maximum cell spreading area occurring on polyacrylamide
substrates of an intermediate stiffness (E=5 kPa) (Fig. 4A). In
contrast, we observed that these same five cell lines exhibited a
direct relationship between spreading area and collagen density
across the range of 0.0001–0.1 mg/mL, with increased area
correlating with increased collagen density (Fig. 4B).
To further investigate the role of cell area in the generation of
traction forces, we analyzed the net traction force (|F|) of each cell
normalized by its projected area (|F|/A) as a measurement of
average traction stress. When the traction forces of cells plated on
Metastatic Cells Exert Increased Traction Force
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e32572substrates of variable stiffness were normalized by their respective
areas, average traction stress increased with increasing stiffness
(p,0.0001, Fig. 5A). Therefore, the increased force on stiffer
substrates is not due to increased cell spreading. However, the
average traction stress of cells plated on substrates of variable
collagen density revealed an overall equalization of forces across
the collagen concentrations tested (Fig. 5B). These data suggest
that increased collagen density may promote force generation by
causing an increase in cell spreading.
Metastatic cells exert increased force in an isogenic
model
Because the cell lines used in these experiments are of
genetically distinct lineages, we further investigated our hypoth-
esis that metastatic cells generated increased traction forces
compared to non-metastatic cells using an isogenic cell model: the
10AT series of cell lines. The 10AT series consists of several well-
characterized cell lines which represent the full spectrum of
Figure 1. Metastatic cancer cells exert greater forces than non-metastatic cells. (A) Representative traction maps (left), corresponding
phase images (middle), and overall net traction force (|F|, right) of non-metastatic mammary epithelial (MCF10A) and highly metastatic (MDAMB231)
cancer cells. (B) Representative traction maps (left), corresponding phase images (middle), and |F|( right) of non-metastatic primary prostate epithelial
cells (PrEC) and highly metastatic prostate cancer cells (PC3). (C) Representative traction maps (left), corresponding phase images (middle), and |F|
(right) of non-metastatic bronchial epithelial cells (BEAS2B) and metastatic lung adenocarcinoma cells (A549). All cells are on polyacrylamide
substrates with Young’s Modulus (E)=5 kPa and type I collagen concentration of 0.1 mg/mL. Scale bar=50 mm. Mean+SEM; *** indicates p,0.001.
doi:10.1371/journal.pone.0032572.g001
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force generation. Net traction force (|F|) increases with increasing
substrate stiffness (E=1–10 kPa) for (A) MCF10A non-metastatic
mammary epithelial cells and MDAMB231 metastatic cancer cells, (B)
PrEC non-metastatic primary prostate epithelial cells and PC3 metastatic
prostate cancer cells, and (C) BEAS2B non-metastatic bronchial
epithelial cells and A549 metastatic lung cancer cells. Ligand density
is maintained at 0.1 mg/mL collagen I. 5 kPa data is from Figure 1. Note
also that the metastatic cancer cells (black) exert greater forces than
non-metastatic cells (white) at all matrix stiffness levels studied.
Mean+SEM; * indicates p,0.05; *** indicates p,0.001.
doi:10.1371/journal.pone.0032572.g002
Figure 3. Increased collagen density contributes to increased
force generation. Net traction force (|F|) increases with collagen
density (0.0001–0.1 mg/mL collagen I) for (A) MCF10A non-metastatic
mammary epithelial cells and MDAMB231 metastatic cancer cells, (B)
PrEC non-metastatic primary prostate epithelial cells and PC3 metastatic
prostate cancer cells, and (C) BEAS2B non-metastatic bronchial
epithelial cells and A549 metastatic lung cancer cells. Stiffness is
maintained at E=5 kPa. 0.1 mg/mL collagen I data is from Figure 1.
Note also that the metastatic cancer cells (black) exert greater forces
than non-metastatic cells (white) at all collagen densities studied.
Mean+SEM; * indicates p,0.05; ** indicates p,0.01; *** indicates
p,0.001.
doi:10.1371/journal.pone.0032572.g003
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MCF10CA1a lines [39,44,45], compared to their parental
spontaneously immortalized MCF10A cells used previously in
this work. MCF10AT1 cells were derived from MCF10A cells
transfected with the constitutively active Ha-ras oncogene. These
cells are considered ‘premalignant’ and will first form simple
ducts in nude mice xenografts, followed by benign lesions which
occasionally progress to carcinomas [44]. MCF10CA1a cells were
selectively derived from the MCF10AT1 carcinoma populations.
These cells form undifferentiated carcinomas and rapidly growing
metastases within the lungs [39,44,45]. Together, the MCF10A,
MCF10AT1, and MCF10CA1a are isogenic human cell lines
representative of different stages of metastatic potential: non-
tumorigenic, premalignant, and highly metastatic (Fig. 6A). The
highly metastatic MCF10CA1a derivative exerted significantly
greater traction forces compared to the benign MCF10AT1 and
Figure 4. Cell area is differentially altered by matrix stiffness and collagen density. Projected cell area shows a biphasic relationship with
substrate stiffness (A) and a direct relationship with collagen density (B) in the majority of the metastatic (black) and non-metastatic cells (white)
studied. No consistent trend was observed when comparing the projected cell area of complementary metastatic and non-metastatic cells.
doi:10.1371/journal.pone.0032572.g004
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mimicking the stiffness of tumorigenic breast tissue (E=5 kPa)
[15]. When the net traction force was normalized by projected
area, there was a significant increasing trend in average traction
stress (p,0.001, Fig. 6D). Overall, these data from an isogenic
cell model correlate well with the data from breast, prostate, and
lung cells derived from different genetic backgrounds
(Fig. 1).
Discussion
To date, there is no universal molecular marker of metastasis.
Because of the known role of cellular force in cell migration, we
explored traction force generation as a potential biophysical
marker characteristic of cells with metastatic ability. The results
presented here show that highly invasive breast, prostate, and lung
cancer cells exert significantly greater traction forces than their
Figure 5. Average traction stress increases with stiffness, not collagen density. |F| of each cell is normalized by its projected area (|F|/A) as a
measurement of average traction stress. Average traction stresses increase with increasing substrate stiffness (A) but become relatively uniform with
increasing collagen density (B) in both metastatic (black) and non-metastatic (white) cells studied.
doi:10.1371/journal.pone.0032572.g005
Metastatic Cells Exert Increased Traction Force
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e32572non-invasive epithelial cell counterparts on 2D substrates of
physiologically relevant stiffness and varying collagen density.
These findings indicate that inherent force differences exist in cells
of differing metastatic potential. Additionally, increased matrix
stiffness and ligand density promote increased contractile force
generation in contrasting ways: collagen density appears to lead to
increased cellular force generation by directly mediating cell
spreading, while matrix stiffness appears to increase cell forces
independently of cell spreading.
Previous studies by others have also explored various biophys-
ical traits as potential markers of metastasis. Atomic force
microscopy (AFM) and optical stretching measurements have
shown that metastatic cancer cells are more compliant than benign
cells, both in established cell lines [46,47] and in primary tumor
samples [48]. These data allow speculation that a difference in the
plasticity of cancer cells may contribute to their enhanced
migration away from the primary tumor by allowing them to
more easily maneuver through the ECM. These studies are the
first indications that there are mechanical properties inherent in
some cancer cells that may promote malignant and metastatic
behavior. In our study, we explore another aspect of cell
mechanics, cellular force generation, to show that metastatic
cancer cells from a variety of cancer types exert greater traction
stresses than their non-metastatic counterparts. We speculate that
these higher forces could potentially drive cancer progression by
promoting cellular behaviors such as cell migration, adhesion, and
ECM remodeling during metastatic invasion.
Cellular mechanical properties can also be affected by the
microenvironment. Using particle-tracking microrheology, Baker
et al. showed that cells embedded in 3D matrices are stiffer than
those plated on 2D substrates [29]. They also show that 3D matrix
stiffness and collagen density significantly affect the intracellular
tension in tumor cells, although this relationship is dependent on
both the type of cell and the cell’s transformation state [29,49].
Increased matrix stiffness in turn has been shown to enhance cell
motility in 2D and 3D [28,30], while decreasing the stiffness of the
tumor microenvironment has been shown to inhibit malignant
progression [13,15]. Increased ECM density has been identified as
a risk factor for breast cancer [37], and has also been shown to
promote invasion by enhancing integrin clustering, upregulating
Rho and PI3 kinase activity, and increasing focal adhesion
formation [13,15]. Recently, Levental et. al. has shown that
inhibiting collagen crosslinking increases tumor latency, reduces
cell proliferation, and reduces tumor volume and incidence in a
mouse model [13]. In this work, we have shown that matrix
stiffness and collagen density both mediate cellular force
generation, with cells exerting greater force on substrates with
either increased stiffness or increased collagen density.
Since both matrix stiffness and ligand density have been
associated with increased cell spreading [34,35,36,50,51], we
examined their effects on cell spreading area here. We find that in
the majority of the cell lines employed in this study, there existed a
biphasic relationship between cell spreading and substrate stiffness
(Fig. 4A), but a direct relationship between cell spreading and
collagen density (Fig. 4B). While the relationship between area and
Figure 6. Metastatic derivative in a series of isogenic cell lines
exerts greater forces. (A) Phase images of parental untransformed
cells (MCF10A), transformed premalignant (MCF10AT1) and highly
metastatic (MCF10CA1a) derivatives. (B) Net traction forces increase
with increasing metastatic potential, with the highest forces exerted by
the metastatic MCF10CA1a cells. (C) Average traction stress (|F|/A)
increases with increasing metastatic potential. Mean 6 SEM;
** indicates p,0.01; *** indicates p,0.001.
doi:10.1371/journal.pone.0032572.g006
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cell types [34,35,36], the relationship between substrate stiffness
and cell spreading contrasts with similar studies performed on
several different non-cancerous cell types [34,50,51]. However,
there has been some evidence reported previously that the effect of
matrix stiffness on cell spreading is highly variable and cell type-
specific, particularly in cancer cells [52].
Interestingly, we observe that cells on substrates of increasing
stiffness exhibit increased average traction stresses, while cells on
substrates of increasing collagen density exhibit no change in
average traction stresses (Fig. 5). We speculate that matrix stiffness
is able to promote force generation through a mechanosensing-
mechanism which causes an upregulation of contractility-related
proteins, while collagen density promotes force generation by
controlling the number of available integrin binding sites available
to the cell, therefore directly mediating the cell spreading area and
allowing larger cells to exert greater forces. Importantly, metastatic
cancer cells exert increased force compared to non-metastatic cells
regardless of cell spreading area. This suggests increased force
generation is inherently tied to the metastatic phenotype regardless
of the microenvironment. It is also important to note that while
this data is acquired in a 2D environment, previous work in our
lab has shown that forces in 2D reflect the forces generated within
a 3D environment [42].
While we chose to focus on three of the most common
metastatic cancers (breast, prostate, and lung), we cannot claim
that contractile force will be a universal predictor of metastatic
behavior without thoroughly characterizing every type of cancer.
Indeed, recent work has shown that the method of transformation
or exposure to different tumorigenic signals can significantly affect
cellular mechanical properties in contrasting ways [49,53].
Additionally, a recent study using a series of murine breast cancer
cell lines of increasing metastatic potential observed the reverse
trend to our data, showing that cells of increasing metastatic
potential exert weaker contractile forces [54]. While it is an elegant
model of metastatic potential, the relevance of mouse-derived
cancers to cancers which develop within the human body
continues to be disputed [55]. Based on the data shown in this
study, particularly on the work done using the isogenic MCF10AT
series of cell lines, we believe that pursuing traction force
generation as a mechanical indicator of metastasis could
potentially reveal mechanistic details that will lead to a better
understanding of the initiation and progression of metastatic
cancer. Additionally, examining proteins which are known to play
key roles in mediating cell force, such as RhoA, ROCK, or myosin
light chain phosphatase, may reveal a protein marker for traction
stresses which could be more directly employed clinically to
diagnose metastasis. Further studies will be needed on a broader
range of cancer cells to determine the applicability of this kind of
marker to a wide variety of cancers.
In conclusion, we have shown that metastatic cells exert
significantly greater traction forces than non-metastatic cells in
breast, prostate, and lung cancer models, and that these forces can
be driven by the mechanical and chemical properties of the tumor
microenvironment. These findings suggest that inherent force
differences exist in cells of differing metastatic potential, and that
these differences could be developed into a biophysical marker
that could be used to determine the likelihood of metastasis.
Additionally, our data suggest that identifying a mechanism to
therapeutically target cellular force may be a promising avenue for
inhibiting metastatic progression.
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